Friday, November 22
Shadow

FDA Issues Emergency Use Authorization for Regeneron Monoclonal Antibody Cocktail

by admin

FDA Issues Emergency Use Authorization for Regeneron Monoclonal Antibody Cocktail

qm4o0lzsdo6g8ovlbbo2

The Food and Drug Administration on Saturday issued an emergency use authorization to Regeneron for its covid-19 monoclonal antibody cocktail, which is made up of the antibodies casirivimab and imdevimab, citing a reduction in hospitalizations and emergency room visits in patients in a clinical trial as well as a…

Read more…

Go to Source

Related posts:

  1. FDA Issues Emergency Authorization for Coronavirus At-Home Sample Collection Kit
  2. Why Scientists Are Wary of the FDA’s Emergency Use Authorization of Plasma for Covid-19
  3. FDA Grants Emergency Authorization for Covid-19 Plasma Treatments Because Science Schmience
  4. FDA Grants Emergency Use Authorization for Covid-19 Pool Testing, Which Analyzes Multiple Samples at Once
  5. Eli Lilly’s Covid-19 Antibody Drug Just Received Emergency FDA Clearance
Exit mobile version

Terms and Conditions - Privacy Policy